Report cover image

Australia Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests

Publisher GlobalData
Published Jun 23, 2025
Length 46 Pages
SKU # GBDT20178517

Description

Australia Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests

Summary

GlobalData’s “Australia Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests

The Australia Reproductive Health Diagnostics Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Reproductive Health Diagnostics Market.
  • Global corporate-level profiles of key companies operating within the Australia Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

Australia Reproductive Health Diagnostics is segmented as follows -
  • Prenatal Screening
  • Reproductive Hormones and Proteins Tests
Reasons to Buy

The Australia Reproductive Health Diagnostics Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

46 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Reproductive Health Diagnostics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Reproductive Health Diagnostics Market, Australia
3.1 Reproductive Health Diagnostics Market, Australia, Revenue ($m), 2018-2033
3.1.1 Prenatal Screening Market, Australia, Revenue ($m), by Segment, 2018-2033
3.1.2 Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), by Segment, 2018-2033
3.2 Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
3.2.1 Prenatal Screening Market, Australia, Volume (Units), by Segment, 2018-2033
3.2.2 Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), by Segment, 2018-2033
3.3 Reproductive Health Diagnostics Market, Australia, Average Price ($), 2018-2033
3.4 Reproductive Health Diagnostics Market, Australia, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in Australia, Reproductive Health Diagnostics Market
4.1 Illumina Inc
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Quidelortho Corp
4.3.1 Company Overview
4.4 Danaher Corp
4.4.1 Company Overview
4.5 Siemens AG
4.5.1 Company Overview
4.6 BGI Genomics Co Ltd
4.6.1 Company Overview
4.7 Abbott Laboratories
4.7.1 Company Overview
5 Reproductive Health Diagnostics Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 HeraMED to Raise USD0.31 Million in Second Tranche Private Placement of Shares
6.1.2 Memphasys Raises USD0.66 Million in Private Placement of Shares
6.1.3 Memphasys Raises USD0.57 Million in Share Purchase Plan (SPP)
7 Recent Developments
7.1 Product News
7.1.1 Sep 23, 2024: Memphasys Files Patent for Novel Antioxidant Assay System, RoXsta
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Reproductive Health Diagnostics Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 2: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 3: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 4: Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
Table 5: Prenatal Screening Market, Australia, Volume (Units), 2018-2033
Table 6: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2018-2033
Table 7: Reproductive Health Diagnostics Market, Australia, Average Price ($), 2018-2033
Table 8: Reproductive Health Diagnostics Market, Australia, Company Share by Revenue ($m), 2024
Table 9: Reproductive Health Diagnostics Market Pipeline Products
Table 10: HeraMED to Raise USD0.31 Million in Second Tranche Private Placement of Shares
Table 11: Memphasys Raises USD0.66 Million in Private Placement of Shares
Table 12: Memphasys Raises USD0.57 Million in Share Purchase Plan (SPP)
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Reproductive Health Diagnostics Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 2: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 3: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 4: Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
Figure 5: Prenatal Screening Market, Australia, Volume (Units), 2018-2033
Figure 6: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2018-2033
Figure 7: Reproductive Health Diagnostics Market, Australia, Company Share (%), 2024

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us